BriaCell Therapeutics Corp.

BriaCell is a clinical stage immuno-oncology company that is developing an entirely new class of targeted #immunotherapies to transform cancer care. Please visit our website to learn more: https://bit.ly/3cNVi8a #breastcancer #prostatecancer #metastaticbreastcancer

In a clinical study of 54 patients, Bria-IMT™ regimen used in combination with an immune check point inhibitor was associated with longer than expected progression free survival and other clinical benefits in #metastaticbreastcancer patients. Visit BriaCell's clinical study page to learn more about our pivotal Phase 3 study in metastatic breast cancer: https://lnkd.in/e79ajb2X #breastcancer #MBC #clinicaltrial #newcancertreatments #innovativecancertreatments #innovativecancertherapies #clinicalstudy #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #patientrecruitment #clicaltrial

Five BriaCell posters showcased robust survival and clinical benefit data, plus key biomarker data from Phase 2 trial of Bria-IMT™ in MBC, at the #SABCS24. https://bit.ly/4fbDRIO #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

BriaCell recently reported median OS of 13.7 months in breast cancer patients with central nervous system (CNS) metastasis treated with the Bria-IMT™ regimen alone or in combination with an immune check point inhibitor (CPI) at the #SABC24: https://bit.ly/4fbDRIO #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

BriaCell recently reported median overall survival (OS) of 13.4 months for Ph 2 MBC patients treated with the Ph 3 formulation (15.6 months for those treated since 2022), double that of comparable patients in the literature at the #SABCS24: https://bit.ly/4fbDRIO #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

#ICYMI: Bria-IMT™ + CPI produced cancer-fighting CD8+ T cells infiltration into metastatic tumors and lymphoid tissue, leading to cancer destruction - turning “Cold” tumors and lymph nodes “Hot” on ImmunoPET imaging. https://bit.ly/3ORaBfF #SABCS24 #metastaticbreastcancer #breastcancer #noveltherapies #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #cancervaccines #vaccines #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #MBC #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs

In a clinical study of 54 patients, Bria-IMT™ regimen used in combination with an immune check point inhibitor was associated with longer than expected progression free survival and other clinical benefits in #metastaticbreastcancerpatients. The treatment was well-tolerated. If you or someone you know would like to participate in BriaCell's pivotal Phase 3 study in metastatic breast cancer, please click on the following link: https://bit.ly/4d8P2Sf #breastcancer #MBC #clinicaltrial #newcancertreatments #innovativecancertreatments #innovativecancertherapies #clinicalstudy #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #patientrecruitment #clicaltrial

Cheers to a bright and healthy New Year! Wishing you and your loved ones happiness in the year ahead. - From BriaCell team.

BriaCell team wishes you and your family good health, joy, and cherished moments this holiday season!

In a clinical study of 54 patients, Bria-IMT™ regimen used in combination with an immune check point inhibitor was associated with longer than expected progression free survival and other clinical benefits in #metastaticbreastcancer patients. The treatment was well-tolerated. If you or someone you know has been diagnosed with metastatic breast cancer, please direct them to the following: https://bit.ly/4d8P2Sf #breastcancer #clinicaltrial #newcancertreatments #innovativecancertreatments #innovativecancertherapies #clinicalstudy #cancertherapies #cancerimmunotherapies #oncology #immunotherapies #cancerawareness #cancer #research #biotechnology #innovativetherapies #novelimmunotherapies #cancerdrugs #noveldrugs #cancertreatments #personalizedcancerimmunotherapies #personalizedcancerdrugs #patientrecruitment #clicaltrial